Two vaccines have been approved for Emergency Use Authorisation (EUA) by the National Regulator i.e. Drugs Controller General of India (DCGI). These are “Covishield” manufactured by Serum Institute of India (SII) and “Covaxin” manufactured by Bharat Biotech International Limited (BBIL). Several other vaccines are at various stages of clinical development within the country. The National Regulator grants Permission for Restricted Use in Emergency Situations to Sputnik-V vaccine.
Source: pib.gov.in/PressReleasePage.aspx?PRID=1711342
PDF: COVID-19 Vaccine: Getting Started